← Open Payments lookup

SHARI TOMASETTI: Open Payments

NPI 1972717973 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,307 in 153 payments from 31 companies in 2025. Trend: 2023 $2,661 · 2024 $3,566 · 2025 $3,307

Food & beverage: $3,239Education: $68
CompanyPaymentsAmount
Amgen Inc.16$339
Novo Nordisk Inc13$310
Lilly USA, LLC12$302
Insulet Corporation20$273
Xeris Pharmaceuticals, Inc.13$254
Boehringer Ingelheim Pharmaceuticals, Inc.9$204
Bayer Healthcare Pharmaceuticals Inc.11$197
Astellas Pharma US Inc6$176
TOLMAR, INC.7$161
ABBVIE INC.7$155

Products named: JARDIANCE, Omnipod, Ozempic, Kerendia, JATENZO, RECORLEV, EVENITY, SYNTHROID.

Industry payments across MA — which companies pay providers there.